IMPACT OF DNA DOUBLE-STRAND BREAKS ON 3D GENOME ORGANIZATION AND GENOME STABILITY IN ALZHEIMER'S DISEASE -…
Federal financial assistance recorded from USAspending. This is not a procurement contract.
Research this with AI
Research smarter with AI
Analyze opportunities and compare insights across leading AI models.
ASST_NON_R00AG073466_075 · BAYLOR COLLEGE OF MEDICINE · Department of Health and Human Services
Compare Multiple AI Models with SmartSoloExplore CaptureIQ IntelligenceAssistance award details
- Assistance award identifier
- ASST_NON_R00AG073466_075
- FAIN
- R00AG073466
- Recipient
- BAYLOR COLLEGE OF MEDICINE
- Awarding agency
- Department of Health and Human Services
- Funding agency
- Department of Health and Human Services
- Assistance listing (CFDA)
- 93.866
- Total obligated
- $742,019
- Period
- Aug 15, 2021 – May 31, 2027
- Fiscal year
- 2024
- Place of performance state
- TX
- Source file
- FY2024_All_Assistance_Full_20261006.zip
Description
IMPACT OF DNA DOUBLE-STRAND BREAKS ON 3D GENOME ORGANIZATION AND GENOME STABILITY IN ALZHEIMER'S DISEASE - PROJECT SUMMARY/ABSTRACT THE ACCUMULATION OF DNA DOUBLE-STRAND BREAKS (DSBS) IN NEURONS IS AN EARLY HALLMARK OF ALZHEIMERâS DISEASE (AD). INCREASED DSBS ARE ALSO ASSOCIATED WITH AGING, WHICH IS THE LARGEST RISK FACTOR FOR AD. AD IS ALSO A COMPLEX DISEASE INVOLVING ALL MAJOR BRAIN GLIAL CELL TYPES. THUS, THERE IS A CRITICAL NEED TO UNDERSTAND THE MOLECULAR MECHANISMS OF DSB INDUCED CHANGES IN BOTH NEURONS AND GLIA. THE STRUCTURAL STABILITY OF THE GENOME IS PARAMOUNT IN MAINTAINING A FUNCTIONAL GENOME, AND RECENTLY, THE 3D ORGANIZATION OF THE GENOME HAS EMERGED AS A MAJOR REGULATOR OF GENOME FUNCTION. MY OVERALL HYPOTHESIS IS THAT 3D GENOME REORGANIZATION AND STRUCTURAL GENOME INSTABILITY MEDIATED BY DSBS ARE PRINCIPLE DRIVERS OF AD PATHOGENESIS AND BRAIN AGING. MY OBJECTIVE IS TO DETERMINE HOW AND TO WHAT EXTENT DSBS WITHIN THE NEURONS IMPACT GENOME ORGANIZATION AND THE GLIAL RESPONSE, WITH THE GOAL OF IDENTIFYING MOLECULAR PATHWAYS THAT CAN BE TARGETED AS NOVEL THERAPIES FOR PREVENTING OR HALTING THE PROGRESSION OF NEURODEGENERATION. I WILL USE MOUSE MODELS THAT RECAPITULATE THE PRE-SYMPTOMATIC ACCUMULATION OF DSBS IN NEURONS AND HUMAN IPSC MODELS TO DETERMINE THE DEGREE OF THE 3D GENOME DISRUPTION CAUSED DUE TO DSBS AND THE UNDERLYING MOLECULAR MECHANISMS. I WILL ALSO IDENTIFY THE CONSEQUENCES OF NEURONAL DSBS ON THE STRUCTURAL STABILITY OF THE GENOME BY MEASURING THE FREQUENCY OF DSB MEDIATED CHROMOSOMAL TRANSLOCATIONS IN HUMAN AD NEURONS. INTERESTINGLY, NORMAL NEURONAL ACTIVITY CAUSES DSBS AT IMMEDIATE EARLY GENE PROMOTERS. ALSO, NEURONAL HYPERACTIVITY HAS BEEN REPORTED IN AD. I WILL TEST IF IEGS ARE LOCATIONS OF FREQUENT CHROMOSOMAL TRANSLOCATIONS AFTER NEURONAL HYPERACTIVITY INDUCED IN NEURONAL CULTURE. PREVIOUS STUDIES HAVE SHOWN THAT MICROGLIA TRANSITIONS TO A REACTIVE STATE IN RESPONSE TO NEURODEGENERATION. TO UNDERSTAND THE ROLE OF THE 3D GENOME ORG